HANATOUR SERVICE INC. Logo

HANATOUR SERVICE INC.

South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.

039130 | KO

Overview

Corporate Details

ISIN(s):
KR7039130000
LEI:
Country:
South Korea
Address:
서울특별시 종로구 인사동5길 41 (주)하나투어, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Hanatour Service Inc. is South Korea's largest travel company, providing a comprehensive range of travel services for individual and corporate clients. The company specializes in outbound and inbound travel, offering products such as package tours, customized itineraries, and air ticket sales. It operates through a multi-channel approach, featuring a significant online presence for direct consumer booking and a B2B division, Hanatour Partners, which provides professional consultation. Supported by a large team of product planners and an extensive global network, the company serves a cumulative customer base of over 20 million travelers. Hanatour is also committed to sustainable management, having established the travel industry's first ESG Committee.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 50.6 KB
2025-08-06 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.1 KB
2025-07-31 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.3 KB
2025-07-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 30.2 KB
2025-07-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.5 KB
2025-07-01 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 7.3 KB
2025-06-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 945.0 KB
2025-05-23 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 7.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-05-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.0 KB
2025-05-02 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.3 KB
2025-04-16 00:00
Regulatory News Service
기업가치제고계획(자율공시)
Korean 9.8 KB

Automate Your Workflow. Get a real-time feed of all HANATOUR SERVICE INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HANATOUR SERVICE INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HANATOUR SERVICE INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.